Wird geladen...

Molecular monitoring in chronic myeloid leukemia—how low can you go?

Molecular monitoring of BCR-ABL1 transcripts for patients with chronic myeloid leukemia (CML) is now used to assess response to tyrosine kinase inhibitors (TKIs), including treatment failure that mandates a change of therapy. Therefore, many centers have adopted the molecular technique for measuring...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematology Am Soc Hematol Educ Program
1. Verfasser: Branford, Susan
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142476/
https://ncbi.nlm.nih.gov/pubmed/27913475
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!